Literature DB >> 9489498

Lower-extremity strength profiles in spastic cerebral palsy.

M E Wiley1, D L Damiano.   

Abstract

Although weakness has been identified in cerebral palsy (CP) in isolated muscle groups, the magnitude of weakness in multiple muscles and the patterns of weakness across joints have not been documented. The maximum voluntary contraction of eight muscle groups in the lower extremities of 15 children with spastic diplegia, 15 with spastic hemiplegia, and 16 age-matched peers was determined using a hand-held dynamometer. Children with spastic diplegia were shown to be weaker than age-matched peers in all muscles tested, as were the children with hemiplegia on the involved side, with strength differences also noted on the uninvolved side. Weakness was more pronounced distally in the groups with CP, and the hip flexors and ankle plantarflexors in spastic CP tended to be relatively stronger than their antagonists as compared with the strength ratios of the comparison group. In conclusion, children with spastic CP demonstrate quantifiable lower-extremity weakness and muscle imbalance across joints.

Entities:  

Mesh:

Year:  1998        PMID: 9489498     DOI: 10.1111/j.1469-8749.1998.tb15369.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  83 in total

1.  Temporal characteristics of lower extremity moment generation in children with cerebral palsy.

Authors:  Andrea L Downing; Kathleen J Ganley; Deanne R Fay; James J Abbas
Journal:  Muscle Nerve       Date:  2009-06       Impact factor: 3.217

2.  Comparison of electrical nerve stimulation, electrical muscle stimulation and magnetic nerve stimulation to assess the neuromuscular function of the plantar flexor muscles.

Authors:  Daria Neyroud; John Temesi; Guillaume Y Millet; Samuel Verges; Nicola A Maffiuletti; Bengt Kayser; Nicolas Place
Journal:  Eur J Appl Physiol       Date:  2015-02-15       Impact factor: 3.078

3.  Blood flow restriction increases myoelectric activity and metabolic accumulation during whole-body vibration.

Authors:  Christoph Centner; Ramona Ritzmann; Stephan Schur; Albert Gollhofer; Daniel König
Journal:  Eur J Appl Physiol       Date:  2019-04-04       Impact factor: 3.078

4.  The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study.

Authors:  Lee Barber; Tandy Hastings-Ison; Richard Baker; H Kerr Graham; Rod Barrett; Glen Lichtwark
Journal:  J Child Orthop       Date:  2013-06-18       Impact factor: 1.548

Review 5.  Health-related physical fitness for children with cerebral palsy.

Authors:  Désirée B Maltais; Lesley Wiart; Eileen Fowler; Olaf Verschuren; Diane L Damiano
Journal:  J Child Neurol       Date:  2014-05-11       Impact factor: 1.987

6.  Voluntary muscle activation, contractile properties, and fatigability in children with and without cerebral palsy.

Authors:  Scott K Stackhouse; Stuart A Binder-Macleod; Samuel C K Lee
Journal:  Muscle Nerve       Date:  2005-05       Impact factor: 3.217

Review 7.  Complicated Muscle-Bone Interactions in Children with Cerebral Palsy.

Authors:  Christopher M Modlesky; Chuan Zhang
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

8.  Leg strength, preferred walking speed, and daily step activity in adults with incomplete spinal cord injuries.

Authors:  Sandra L Stevens; Dana K Fuller; Don W Morgan
Journal:  Top Spinal Cord Inj Rehabil       Date:  2013

9.  Muscle plasticity and ankle control after repetitive use of a functional electrical stimulation device for foot drop in cerebral palsy.

Authors:  Diane L Damiano; Laura A Prosser; Lindsey A Curatalo; Katharine E Alter
Journal:  Neurorehabil Neural Repair       Date:  2012-10-04       Impact factor: 3.919

10.  In vivo muscle architecture and size of the rectus femoris and vastus lateralis in children and adolescents with cerebral palsy.

Authors:  Noelle G Moreau; Sharlene A Teefey; Diane L Damiano
Journal:  Dev Med Child Neurol       Date:  2009-04-21       Impact factor: 5.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.